COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222

NCT04864561 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4034

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Virus Infection

Interventions

BIOLOGICAL: VLA2001
BIOLOGICAL: AZD1222
BIOLOGICAL: VLA2001 - adolescent part
BIOLOGICAL: Placebo

Sponsor

Valneva Austria GmbH